Chinese clinical-stage innovative drug developer Kangpu Biopharmaceuticals unveiled on Friday that it has raised nearly RMB100 million (US$14.18 million) in a series pre-B round of financing.
Chinese Clinical-Stage Innovative Drug Developer Kangpu Raises Nearly $14M comes originally from China Money Network. All Rights Reserved.